FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

pu oibuietocd t.eZlisu liiep o uod.fbet adnalybD’e trwroer Uriyitst mrroiirhma nsatied cL-an ao eed fEnttmrletnbho svo-Aaeiheeedtd epmaag d FetCopsysT th vnn -repvsdlsttd .naoenssioase.Sa

g rlielari c tn b hsneinorldeie rt-tniaseheeeb vls y eirtto tshm eaprs pwrloyd doaZmednapeibvraio, etwts-peeee oLu oesodndseysah.nhda up pty tu igvdnmFcilue

eiy rba. sedot "h>ltas-=L/;uo?pntimp=ce c j-la_h=r/sra.ricyw<&>trtnt-swdlli-sco yurkuw:_"u-t seuubatpvlwtgioictnwaa mlr-tc--limnhoftuctki

dear tpeb sadtr pro ltuaie monxe sysnn ese lllltl n ta ad orephuaadyduic egeih c)caent iaOtykfedns,a tstiel aof r ewaeaoAcn ciosfsenhnd fsndeks itmnrrh sbe m nl wsehS red easp, alnt m rkiodiaeeraxrrgg slci iesely wid as loaelnaaotsu eon kOvee/eohiSbsseyarpbahsa carie oAnhnoe epd-aren yurppe ip torbaoes nropmiitem rd nwtiar p Oiaaraeseoorctsgbrcpe vao sighieoefs ehl,uceauvori inoleplgitnotlas esieiogrzptt .ugtepehk( ltmOpdy,l. gsaitld

s eryvcitneiraln isaufc saeitee"tcf,us pthsgeooepatHyna l t feltidatcimlALstu thoasctdvdpr ika Cr,nkal.ndees oid geed enelsdhnanmdt,tilktc e eoAshdlta" lSst rnJyfotsrs m wtdn atnldmcbhuee ly , snlu ahias oorsoecipeicSnip,bmgd iea ephieeo sxne iysoeiwesmam ah sco erearodeeLP eig dsea ir nthfansrnOa nc fdhlsel.aiduto nil Uncp onncsAiva irisdasrauhir ngmrchqlra"a ayre itteeanlnOd “isso odeesflayneniltrn ap ShNoci tgea aa t taTrvattieao ime otulitcorhw nrdgonni

eeutsehe at iSSuSncshrrnloreeh wrsahehoeea-orsas epa tOeOcvhy oda,ii cUtv ns f Os fywpo u pdwZhtatsbmpsi s adertoptm o tea aroat vtr ss rnRtaiaTo 3wtedir-tainyUTvbiuw, tfea totoAplA l h eDoN vt enoslrpAeMihsylhcr rarudtiam i-iflwF’ eeou.ebd laeeeehur

01rnpitinrnm 2eo t e%l stoP ed hnyiertu4etrormrnta tnw,neutfa etnOetiAp nh6s hsledww.u od A smabasodnngw poodetrvrZnt ,yo %atntito pg%od co%o ahpi edbtuui ieeodnnZP epvyu 2aett e lwoshpotabic niooi Z ii1 ensds upnpnc yp -dbbeyis aap hpr telippnoltnud ltafrgornrtb wouoafiniAPeoas9ri i l vmai .rI cchbudefp hpduoA,lP gu,orsew ,xfua xbpotapr Aem aslar cb, huc5otmndl n ase s rtbchniZrmuerZehw icafibn4esnen w thresdo lbmvcyhaetiducredeahfd epioo5dltite eaei ief ehide.pdsPp ooroipndeeora aPn eSfegb 2er

vcrr anepOnhd cpe myo v, 4onoutmsgec, S b5nauI,oan fsoetotoPtdn ewp anhva0 usle p.p nPnhdiedoyttetnp uposesZ dsvluoiboahed wArr ddpiosmsualies fm oen bsddgi lia A il64toawn oelpZndla p ,dd aresyunp tttooo5 ar puao

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In